首页|分级诊疗模式下儿童过敏性哮喘的合理用药管理策略

分级诊疗模式下儿童过敏性哮喘的合理用药管理策略

扫码查看
过敏性疾病,尤其是过敏性哮喘,已成为21世纪儿童健康的重大挑战,其发病率在我国呈上升趋势.儿童过敏性哮喘不仅严重影响患儿的身心健康,还对家庭和社会造成沉重的经济负担.本文旨在探讨在分级诊疗模式下,如何通过合理用药管理来优化儿童过敏性哮喘的治疗.早期识别哮喘急性发作并进行快速抗炎治疗,结合动态监测疗效调整药物剂量,对于避免联合用药的不良反应风险至关重要.此外,对于适宜的患者,早期引入标准化的过敏原特异性免疫治疗和生物制剂治疗,完善慢性气道炎症的全程管理路径.通过个体化的过敏健康教育和上下联动的延续性治疗,可以提升治疗依从性,实现精准治疗和完全控制,改善气道过敏的预后.本文拟为现阶段儿童过敏性哮喘的诊治提供借鉴与参考.
Rational Drug Use Management Strategies for Childhood Allergic Asthma in the Model of Hierarchical Medical Care
Allergic diseases,particularly allergic asthma,have emerged as a significant challenge to children's health in the 21st century,with its incidence rate on the rise in China.Childhood allergic asthma not only profoundly impacts the physical and mental well-being of affected children but also imposes a substantial economic burden on families and society.This article aims to explore how to optimize the treatment of childhood allergic asthma through rational drug administration under the policy of hierarchical medical care.Early identification of acute asthma exacerbations and prompt anti-inflammatory treatment,coupled with dynamic monitoring of therapeutic effects for adjusting drug dosages,are of paramount importance in avoiding the risk of adverse reactions from combined drug use.Moreover,for eligible patients,the early introduction of standardized allergen specific immunotherapy and biological agent therapies has completed the entire management pathway for chronic airway inflammation.Through individualized allergy health education and coordinated continuous treatment across different levels,treatment compliance can be enhanced,precise treatment and complete control can be achieved,and the prognosis of airway allergies can be improved.This paper intends to offer references and guidance for the diagnosis and treatment of childhood allergic asthma at the present stage.

childrenallergic asthmahierarchical medical carerational drug use managementprognosis

向莉、皇惠杰、岳纯宜

展开 >

国家儿童医学中心,儿科重大疾病研究教育部重点实验室,国家呼吸系统疾病临床医学研究中心,首都医科大学附属北京儿童医院过敏反应科,北京 100045

儿童 过敏性哮喘 分级诊疗 合理用药管理 预后

2024

中国合理用药探索
中国执业药师协会

中国合理用药探索

影响因子:0.62
ISSN:2096-3327
年,卷(期):2024.21(11)